A detailed history of Barclays PLC transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Barclays PLC holds 100 shares of XPH stock, worth $3,945. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$3,945
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

SELL
$35.2 - $41.92 $3,520 - $4,192
-100 Reduced 50.0%
100 $4,000
Q3 2023

Nov 07, 2023

BUY
$39.75 - $44.12 $3,975 - $4,412
100 Added 100.0%
200 $8,000
Q4 2021

Feb 14, 2022

SELL
N/A
-110 Reduced 52.38%
100 $5,000
Q3 2021

Nov 09, 2021

SELL
N/A
-734 Reduced 77.75%
210 $10,000
Q2 2021

Aug 13, 2021

BUY
N/A
844 Added 844.0%
944 $49,000
Q1 2020

May 13, 2020

SELL
N/A
-47,300 Reduced 99.79%
100 $4,000
Q2 2019

Aug 14, 2019

SELL
N/A
-150,000 Reduced 75.99%
47,400 $1.89 Million
Q1 2019

May 15, 2019

BUY
N/A
150,000 Added 316.46%
197,400 $8.21 Million
Q4 2018

Feb 14, 2019

BUY
N/A
47,400 New
47,400 $1.74 Million

Others Institutions Holding XPH

About SPDR SER TR SPDR S&P PHARMACEU


  • Ticker XPH
  • Sector ETFs
  • Industry ETFs
More about XPH
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.